← Back to Search

Pure-Vu EVS for Colorectal Screening

N/A

Recruiting

Led By Aasma Shaukat, MD

Research Sponsored by Motus GI Medical Technologies Ltd

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year.

Awards & highlights

Study Summary

This trial tests a device to help make sure colonoscopies are done properly, so they can be effective.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Colonoscopy

Secondary outcome measures

Assessment Screening

Assessment of Screening

Assessment screening

+2 more

Other outcome measures

Comparison Rates

Economic Impact

User Satisfaction

Trial Design

1Treatment groups

Experimental Treatment

Group I: Pure-Vu EVSExperimental Treatment1 Intervention

Rate of incomplete colonoscopies due to inadequate preparation salvaged to adequate colonoscopies with the use of the Pure-Vu EVS System. Inadequate OCs defined as such if any of the following are met: BBPS < 6 (Adequacy is defined as BBPS of 2 or greater in each segment) Inability to identify > 5mm polyps The estimated rate of salvaged preparations will be calculated and presented with exact one-sided 95% confidence interval: Number of preps inadequate with SOC and adequate after Pure-VU EVS System / Number of preps inadequate with SOC. The lower bound will be compared to a 35% performance goal.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Motus GI Medical Technologies LtdLead Sponsor

12 Previous Clinical Trials

348 Total Patients Enrolled

Aasma Shaukat, MDPrincipal InvestigatorNYU Langone.org

Media Library

Pure-Vu EVS Clinical Trial Eligibility Overview. Trial Name: NCT05585879 — N/A

Colorectal Screening Research Study Groups: Pure-Vu EVS

Colorectal Screening Clinical Trial 2023: Pure-Vu EVS Highlights & Side Effects. Trial Name: NCT05585879 — N/A

Pure-Vu EVS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05585879 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the size of the cohort enrolled in this research endeavor?

"Affirmative. The clinicaltrials.gov webpage reflects that the trial, first posted on November 3rd 2022 is still actively recruiting individuals to participate. It is expected that 1067 patients from two different sites are needed for this experiment."

Answered by AI

Are participants aged 20 and above qualified to join this trial?

"This clinical trial welcomes individuals who are 40 years and older but not yet 80."

Answered by AI

Has recruitment for this trial commenced yet?

"This trial is still seeking applicants, as reported on clinicaltrials.gov. The initial posting was made November 3rd 2022 and the latest update occurred November 15th of the same year."

Answered by AI

Is there any way I can participate in this research project?

"To gain admittance to the trial, applicants must have undergone mutagenicity tests and fall into the age range of 40-80. At present there are approximately 1067 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Demonstrating Effective Salvage of Inadequate Colonoscopies

2022. "Demonstrating Effective Salvage of Inadequate Colonoscopies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05585879.